NCT07154394 · RECRUITING
Cardiac Amyloid Deposits and Heart Dysfunction in Alzheimer's Disease
This study uses PET and MRI scans to look at amyloid deposits in both the brain and the heart at the same time. Researchers want to know whether the same amyloid buildup that drives Alzheimer's also damages the heart. Participants are people already scheduled for a brain amyloid PET scan for clinical reasons. This is an observational study with no phase — it is not testing a drug, just gathering imaging data to better understand a possible connection.
You may qualify if
- Patients undergoing cerebral amyloid PET examination for clinical indication to clarify Alzheimer's disease
- No contraindications to undergo an MRI examination
- No contraindications to undergo an Amyloid PET scan
You're excluded if
- Patients with vascular dementia and confirmed other causes of dementia (e.g. stroke, vitamin deficiency, thyroid insufficiency, toxic causes such as alcohol)
- Patients with pronounced cardiac preconditions
- Pregnant and breastfeeding women
The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.
Eligibility criteria as of 2025-09-04